NCT04584424 is a clinical trial of The study does not required in Epidemiology, sponsored by Ethiopian Public Health Institute.

Who is sponsoring NCT04584424?

NCT04584424 is sponsored by Ethiopian Public Health Institute.

What drugs are being tested in NCT04584424?

Interventions in NCT04584424: The study does not required.

What condition does NCT04584424 study?

NCT04584424 studies Epidemiology, Clinical, Nutritional-status, Immunologic Defect.

Is NCT04584424 still recruiting?

NCT04584424 is currently completed. Last updated 19 September 2024.

Last reviewed 2024-09-19 · How we verify

NCT04584424

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prognostic Factors and Outcomes of COVID-19 Cases in Ethiopia

Completed Last updated 19 September 2024

What this trial tests

trial testing The study does not required in Epidemiology in 6,390 participants. Completed in 14 November 2022.

Timeline

30 October 2020

Primary endpoint
14 November 2022

14 November 2022

Quick facts

Lead sponsor	Ethiopian Public Health Institute
Status	Completed
Study type	OBSERVATIONAL
Enrollment	6,390
Start date	30 October 2020
Primary completion	14 November 2022
Estimated completion	14 November 2022
Sites	1 location across Ethiopia

Drugs / interventions tested

The study does not required

Conditions studied

Epidemiology — all drugs for Epidemiology →
Clinical — all drugs for Clinical →
Nutritional-status — all drugs for Nutritional-status →
Immunologic Defect — all drugs for Immunologic Defect →

Sponsor

Ethiopian Public Health Institute

Who can join

Eligibility, any sex, with Epidemiology or Clinical. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study will be to determine the epidemiological and clinical features of COVID-19 cases, immunological and virological courses, interaction with nutritional status, and response to treatment for COVID-19 patients admitted to treatment centers in Ethiopia. Methods: This multi-site cohort enrolls, patients with confirmed COVID-19 infection admitted to treatment centers will be enrolled irrespective of their symptoms and followed up for 12 months. Baseline epidemiological, clinical, laboratory and imaging data will be collected from treatment records, interviews, physical measurements and biological samples. Endline data involves treatment and prognostic outcomes to be measured using different biomarkers and clinical parameters, The patients will be followed up in the selected treatment centers for COVID-19 infection. For all data collected both descriptive and multivariable analyses will be performed to isolated determinants of the treatment outcome and prognosis to generate relevant information for informed prevention and case management.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Prognostic factors and outcomes of COVID-19 cases in Ethiopia: multi-center cohort study protocol.
Abdella S, Tessema M, Tasew G, Defar A, et al · · 2021 · cited 4× · PMID 34530744 · DOI 10.1186/s12879-021-06652-0
Distinct proteomic signatures in Ethiopians predict acute and long-term sequelae of COVID-19.
Wolday D, Gebrehiwot AG, Le Minh AN, Rameto MA, et al · · 2025 · cited 1× · PMID 40475767 · DOI 10.3389/fimmu.2025.1575135
Distinct proteomic signatures in Ethiopians predict acute and long-term sequelae of COVID-19
Wolday D, Gebrehiwot AG, Rameto MA, Abdella S, et al · · 2024 · DOI 10.1101/2024.10.09.24315196

Verify or expand the search:

Other recruiting trials for Epidemiology

Currently open trials in the same condition.

NCT06553586 — Epidemiology of Road Traffic Accidents in Riyadh Region in the Last Five Years (2019-2023) · recruiting
NCT07155148 — Argentine Registry of Crohn's Disease and Ulcerative Colitis · recruiting
NCT04889053 — Coronary Artery Calcification in Type 2 Diabetes Mellitus (USCAC Study) · recruiting
NCT05261607 — Analysis of the Evolution of Mortality in an Intensive Care Unit · recruiting

Other Ethiopian Public Health Institute trials

Trials by the same sponsor.

NCT05682261 — The Effect of Multiple Micronutrient Supplements in Reducing Anemia in Women of Reproductive Age · NA · completed
NCT05669209 — Causes of Anemia Among Women of Reproductive Age · completed
NCT03394963 — Developing and Validating Food-based Dietary Guidelines and a Healthy Eating Index · completed
NCT02363985 — Using Stable Isotope Techniques to Monitor and Assess the Vitamin A Status of Children Susceptible to Infection · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04584424 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ethiopian Public Health Institute
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04584424.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing